Physician profile
Pritha P Gupta
NPI 1003133422
$1,909.77
in general payments reported to CMS, 2019-2025
11 companies · $333 in 2025
The $333 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2021: $220 · 2022: $159 · 2023: $498 · 2024: $119 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $931 · Education: $18.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $931.26 |
| Education | $18.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $490.76 | 2019-2025 | Jardiance |
| Amgen INC. | $303.26 | 2021-2023 | Tavneos |
| E.R. Squibb & Sons, L.L.C. | $285.12 | 2025 | Camzyos |
| Sanofi-Aventis U.S. LLC | $234.93 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $173.38 | 2022-2023 | Evkeeza |
| Bayer Healthcare Pharmaceuticals INC. | $121.90 | 2023 | |
| Kiniksa Pharmaceuticals International, Plc | $119.10 | 2024 | Arcalyst |
| Lantheus Medical Imaging, INC. | $97.92 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $38.80 | 2021 | |
| Novartis Pharmaceuticals Corporation | $28.60 | 2025 | |
| Edwards Lifesciences Corporation | $16.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pritha Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.